Caution cluster · stop signs
Red-flag notes: know when to pause
A single unclear detail may have a simple answer. A stack of missing details is a reason to stop and verify before paying.
The checkout comes before the clinical conversation
Slow the process down. A prescription product needs a real prescriber, a real assessment and a pharmacy that can be checked.
Hard stops
Do not let labels do the thinking
- No prescription is required.
- The product says research use while the page promises human effects.
- The only assessment is a fixed form.
- The pharmacy is not named.
- A compounded product is called FDA-approved.
- A listing number such as an NDC is used as proof of approval.
As of September 2026, it was against the law to sell a prescription-only medicine to someone who had no prescription.
Source: Federal prescription law
As of September 2026, stamping “research use only” on a product did not turn it into lawful medical care if the seller’s website pointed it at people.
Source: FDA letter search
As of September 2026, any claim that a compounded medicine was FDA-approved was a false claim.
Source: FDA compounding guide
As of September 2026, a National Drug Code, or NDC, did not show that the FDA approved the product.
Source: Federal registration rule
Verify
Use records, not badges
Get the exact clinician and pharmacy names. Search the relevant state boards. If the label names an outsourcing facility, the larger plant that the FDA registers and inspects, search the FDA’s list of those plants as well.
A state pharmacy licence record is the basic check for the pharmacy named on the label.
Source: FDA pharmacy licence search
As of September 2026, FDA registration was not FDA approval.
Source: Federal registration rule
An FDA warning letter records what the FDA said was wrong when it was sent; it is not a court ruling, and the company may have fixed the problem since, so treat it as a reason to ask questions.
Source: FDA letter search
A fixed questionnaire with no useful follow-up is not a proper medical assessment under medical board guidance.
Leave with four things written down
- The clinician.
- The clinician’s state board.
- The pharmacy.
- The exact medicine on the label.